Combined detection of coronary artery disease and lung cancer

European Heart Journal

Volumn 35, Issue 40, 2014, Pages 2792-2796

  Hecht, Harvey S ^a   Henschke, Claudia ^a   Yankelevitz, David ^a   Fuster, Valentin ^a   Narula, Jagat ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CARDIAC IMAGING; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; EARLY CANCER DIAGNOSIS; HUMAN; LUNG CANCER; NOTE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; COMPLICATION; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; LUNG NEOPLASMS; NEOPLASMS, RADIATION-INDUCED;

CORONARY ARTERY DISEASE; COST-BENEFIT ANALYSIS; EARLY DIAGNOSIS; HUMANS; LUNG NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84920906306     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu296     Document Type: Note

References (36)

1. Hecht HS. Coronary artery calcium: utilization for primary prevention ofCHD. Curr Cardiol Rep 2011;6:465-474.
2. US. Preventive Services Task Force. Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2009;151:474-482.
3. Greenland P, Alpert JS, Beller GA. American College of Cardiology Foundation; American Heart Association. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2010;56:e50-e103.
4. Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O'Gara P, Rubin GD. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. J Am Coll Cardiol. 2010;56:1864-1894.
5. Perk J,DeBacker G, Gohlke H, GrahamI, Reiner Z, VerschurenM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C,Wood D, Zamorano JL, Zannad F. ESC Committee for Practice Guidelines (CPG)European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012;33:1635-1701.
6. Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB, McBride P, Eckel RH, Schwartz JS, Goldberg AC, Shero ST, Gordon D, Smith SC Jr., Levy D, Watson K, Wilson PWF. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. J Am Coll Cardiol 2013; doi: 10.1016/j.jacc.2013.11.002.
7. Goff DC Jr., Lloyd-Jones DM, Bennett G. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol 2014; doi:10.1016/j.jacc.2013.11.005.
8. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, Greenland P. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010;303:1610-1616.
9. Erbel R, Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, Dragano N, Grönemeyer D, Seibel R, Kälsch H, Bröcker-Preuss M, Mann K, Siegrist J, Jö ckel KH. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis. The Heinz Nixdorf Recall Study. J Am Coll Cardiol. 2010;56:1397-1406.
10. Elias-Smale SE, Proenca RV, Koller MT. Coronary calcium score improves classification of coronary heart disease risk in the elderly: The Rotterdam study. J Am Coll Cardiol. 2010;56:1407-1414.
11. Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Matthew J, Budoff MJ. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006;185:394-399.
12. Orakzai RH, Nasir K, Orakzai SH, Kalia N, Gopal A, Musunuru K, Blumenthal RS, Budoff MJ. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. Am J Cardiol. 2008; 101:999-1002.
13. Taylor AJ, Bindeman J, Feuerstein I, Le T, Bauer K, Byrd C, Wu H, O'Malley PG. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. J Am Coll Cardiol. 2008; 51:1337-1341.
14. Rozanski A, Gransar H, Shaw LJ, Johanna Kim J, Miranda-Peats L,Wong ND, Rana JS, Orakzai R, Hayes SW, Friedman JD, Thomson LEJ, Polk D, Min J, Budoff MJ, Berman DS. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing: the EISNER (early identification of subclinical atherosclerosis by noninvasive imaging research) prospective randomized trial. J Am Coll Cardiol. 2011;57:1622-1632.
15. Brugts JJ, Yetgin T, Hoeks SE. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-Analysis of randomised controlled trials. BMJ. 2009;338:b2376.
16. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006; 355:1763-1771.
17. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. New Engl J Med. 2011;365:395-409.
18. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: lung cancer screening. Version 1, 2013. http://www.respiratory-thessaly.gr/assets/lung-screening%20.1.2013.pdf.
19. Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris D, AlbertsWM.Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2013; 143(5-Suppl.):7S-37S.
20. Wender R, Fontham ETH, Barrera E. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-117.
21. Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, Strauss GM, Swanson SJ, Travis WD, Sugarbaker DJ. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012;144:33-38.
22. American Lung Association. Providing guidance on lung cancer screening to patients and physicians. 2012. http://www.lung.org/lung-disease/lung-cancer/lungcancer-screening-guidelines/lung-cancer-screening.pdf (23 April).
23. Moyer VA, on behalf of the US Preventive Services Task Force. Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2014;160:330-338.
24. Smith JP, Yankelewitz DF. Understanding the core result of the National Lung Screening Trial. N Engl J Med 2013;368:1460-1461.
25. Nair A, Hansell DM. European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol 2011;21: 2445-2454.
26. Field JK, van Klaveren R, Pedersen JH, Pastorino U, Paci E, Becker N, Infante M, Oudkerk M, de Koning HJ. European Randomized Screening Trial Group. European randomized lung cancer screening trials: Post NLST. J Surg Oncol. 2013;108: 280-286.
27. Polonsky TS, Greenland P. Coronary artery calcium scores using nongated computed tomography. What to do with incidental results? Circ Cardiovasc Imaging. 2013;6:494-9528.
28. Ioannidis JPA. More than a billion people taking statins? Potential implications?of the new cardiovascular guidelines. JAMA 2014;311:463-464.
29. Xie X, Zhao Y, de Bock GH, de Jong PA, Mali WP, Oudkerk M, Vliegenthart R. Validation and prognosis of coronary artery calcium scoring in nontriggered thoracic computed tomography systematic review and meta-Analysis. Circ Cardiovasc Imaging. 2013;6:514-521.
30. Shemesh J, Henschke CI, Shaham D, Yip R, Farooqi AO, Cham MD, McCauley DI, Chen M, Smith JP, Libby DM, Pasmantier MW, Yankelevitz DF. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest predicts deaths from cardiovascular disease. Radiology 2010;257:541-548.
31. Takx RAP, de Jong PA, Leiner T, Oudkerk M, de Koning HJ, Mol CP, Viergever MA, Isgum I. Automated coronary artery calcification scoring in non-gated chest CT: agreement and reliability. PLoS ONE 2014;9:e91239. doi:10.1371/journal. pone.0091239.
32. American Association of Physicists in Medicine Position Statement on Radiation Risks from Medical Imaging Procedures. PP 25-A 2011.
33. Picano E, Vano E, RehanMM.The appropriate and justified use of medical radiation in cardiovascular imaging: a position document of the ESC Associations of Cardiovascular Imaging, Percutaneous Cardiovascular Interventions and Electrophysiology. Eur Heart J 2014;35:665-672.
34. Larke FJ, Kruger RL, Cagnon CH, Flynn MJ, McNitt-Gray MM, Wu X, Judy PF, Cody DD. Estimated radiation dose associated with low-dose chest CT of averagesize participants in the National Lung Screening Trial. Am J Roentgenol. 2011;197: 1165-1169.
35. Bittencourt MS, Blaha MJ, Blankstein R, Budoff M, Vargas JD, Blumenthal RS, Agatston AS, Nasir K. Polypill therapy, subclinical atherosclerosis, and cardiovascular events-implications for the use of preventive pharmacotherapy. MESA (multiethnic study of atherosclerosis). J Am Coll Cardiol. 2014;63:434-443.
36. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D'Orsi C, Jong R, Rebner M. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005; 353:1773-1783.